AstraZeneca PLC ADR Falls Monday, Underperforms Market

Dow Jones
04-08

DJ AstraZeneca PLC ADR Falls Monday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

The AstraZeneca PLC ADR $(AZN)$ slid 3.90% to $65.79 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.10% to 15,603.26 and the Dow Jones Industrial Average falling 0.91% to 37,965.60.

This was the ADR's second consecutive day of losses.

AstraZeneca PLC ADR closed 24.96% below its 52-week high of $87.68, which the company reached on August 30th.

The ADR underperformed when compared to some of its competitors Monday, as Eli Lilly & Co. $(LLY)$ fell 1.96% to $723.73, Biogen Inc. $(BIIB)$ fell 3.08% to $119.19, and Johnson & Johnson $(JNJ)$ fell 1.71% to $150.62.

Trading volume (11.9 M) eclipsed its 50-day average volume of 5.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled April 7, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

April 07, 2025 17:22 ET (21:22 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10